Differential regulation of HMG-CoA reductase and Insig-1 by enzymes of the ubiquitin-proteasome system

Molecular Biology of the Cell

Volumn 23, Issue 23, 2012, Pages 4484-4494

  Tsai, Yien Che ^a   Leichner, Gil S ^b,c   Pearce, Margaret M P ^d,e   Wilson, Gaye Lynn ^a   Wojcikiewicz, Richard J H ^d   Roitelman, Joseph ^b,c   Weissman, Allan M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SHEBA MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d State University of New York Upstate Medical University: College of Medicine   (United States)

^e STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; PROTEASOME; PROTEIN; PROTEIN INSIG 1; STEROL; UBIQUITIN; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; EMBRYO; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM ASSOCIATED DEGRADATION; FIBROBLAST; FIBROBLAST CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; REGULATORY MECHANISM; RNA INTERFERENCE;

ACYL COENZYME A; ANIMALS; ENDOPLASMIC RETICULUM; HYDROXYMETHYLGLUTARYL COA REDUCTASES; MEMBRANE PROTEINS; MICE; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEOLYSIS; RECEPTORS, AUTOCRINE MOTILITY FACTOR; STEROLS; UBIQUITIN;

EID: 84870495262     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E12-08-0631     Document Type: Article

References (57)

1. Brown MS, Faust JR, Goldstein JL, Kaneko I, Endo A (1978). Induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts incubated with compactin (ML-236B), a competitive inhibitor of the reductase. J Biol Chem 253, 1121-1128. (Pubitemid 8288831)
2. Brown MS, Goldstein JL (1980). Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth. J Lipid Res 21, 505-517. (Pubitemid 11194847)
3. Chen B, Mariano J, Tsai YC, Chan AH, Cohen M, Weissman AM (2006). The activity of a human endoplasmic reticulum-associated degradation E3, gp78, requires its Cue domain, RING finger, and an E2-binding site. Proc Natl Acad Sci USA 103, 341-346. (Pubitemid 43122402)
4. Cheng J, Kang X, Zhang S, Yeh ET (2007). SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia. Cell 131, 584-595. (Pubitemid 350007694)
5. Chun KT, Bar-Nun S, Simoni RD (1990). The regulated degradation of 3-hydroxy-3-methylglutaryl-CoA reductase requires a short-lived protein and occurs in the endoplasmic reticulum. J Biol Chem 265, 22004-22010. (Pubitemid 120014256)
6. Court DL, Swaminathan S, Yu D, Wilson H, Baker T, Bubunenko M, Sawitzke J, Sharan SK (2003). Mini-lambda: a tractable system for chromosome and BAC engineering. Gene 315, 63-69. (Pubitemid 37214898)
7. Custer MC, Risinger JI, Hoover S, Simpson RM, Patterson T, Barrett JC (2006). Characterization of an antibody that can detect the Kai1/CD82 murine metastasis suppressor. Prostate 66, 567-577.
8. Edwards PA, Lan SF, Fogelman AM (1983). Alterations in the rates of synthesis and degradation of rat liver 3-hydroxy-3-methylglutaryl coenzyme A reductase produced by cholestyramine and mevinolin. J Biol Chem 258, 10219-10222. (Pubitemid 14241176)
9. Engelking LJ, Kuriyama H, Hammer RE, Horton JD, Brown MS, Goldstein JL, Liang G (2004). Overexpression of Insig-1 in the livers of transgenic mice inhibits SREBP processing and reduces insulin-stimulated lipogenesis. J Clin Invest 113, 1168-1175. (Pubitemid 38544102)
10. Faust JR, Luskey KL, Chin DJ, Goldstein JL, Brown MS (1982). Regulation of synthesis and degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase by low density lipoprotein and 25-hydroxycholesterol in UT-1 cells. Proc Natl Acad Sci USA 79, 5205-5209.
11. Goldstein JL, Basu SK, Brown MS (1983). Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. Methods Enzymol 98, 241-260. (Pubitemid 14219888)
12. Goldstein JL, Brown MS (1990). Regulation of the mevalonate pathway. Nature 343, 425-430.
13. Goldstein JL, DeBose-Boyd RA, Brown MS (2006). Protein sensors for membrane sterols. Cell 124, 35-46.
14. Hampton RY, Gardner RG, Rine J (1996). Role of 26S proteasome and HRD genes in the degradation of 3-hydroxy-3-methylglutaryl-CoA reductase, an integral endoplasmic reticulum membrane protein. Mol Biol Cell 7, 2029-2044. (Pubitemid 26415008)
15. Hirsch C, Jarosch E, Sommer T, Wolf DH (2004). Endoplasmic reticulum-associated protein degradation - one model fits all? Biochim BiophysActa 1695, 215-223. (Pubitemid 39574975)
16. Irisawa M, Inoue J, Ozawa N, Mori K, Sato R (2009). The sterol-sensing endoplasmic reticulum (ER) membrane protein TRC8 hampers ER to Golgi transport of sterol regulatory element-binding protein-2 (SREBP-2)/SREBP cleavage-activated protein and reduces SREBP-2 cleavage. J Biol Chem 284, 28995-29004.
17. Jackson AL, Bartz SR, Schelter J, Kobayashi SV, Burchard J, Mao M, Li B, Cavet G, Linsley PS (2003). Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol 21, 635-637. (Pubitemid 36638089)
18. Jo Y, Debose-Boyd RA (2010). Control of cholesterol synthesis through regulated ER-associated degradation of HMG CoA reductase. Crit Rev Biochem Mol Biol 45, 185-198.
19. Jo Y, Lee PC, Sguigna PV, DeBose-Boyd RA (2011). Sterol-induced degradation of HMG CoA reductase depends on interplay of two Insigs and two ubiquitin ligases, gp78 and Trc8. Proc Natl Acad Sci USA 108, 20503-20508.
20. Kaneko I, Hazama-Shimada Y, Endo A (1978). Inhibitory effects on lipid metabolism in cultured cells of ML-236B, a potent inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme-A reductase. Eur J Biochem 87, 313-321. (Pubitemid 8355173)
21. Kikkert M, Doolman R, Dai M, Avner R, Hassink G, van Voorden S, Thanedar S, Roitelman J, Chau V, Wiertz E (2004). Human HRD1 is an E3 ubiquitin ligase involved in degradation of proteins from the endoplasmic reticulum. J Biol Chem 279, 3525-3534. (Pubitemid 38140592)
22. Kostova Z, Tsai YC, Weissman AM (2007). Ubiquitin ligases, critical mediators of endoplasmic reticulum-associated degradation. Semin Cell Dev Biol 18, 770-779. (Pubitemid 350138452)
23. Lee JN, Song B, DeBose-Boyd RA, Ye J (2006). Sterol-regulated degradation of Insig-1 mediated by the membrane-bound ubiquitin ligase gp78. J Biol Chem 281, 39308-39315. (Pubitemid 46041890)
24. Lee JN, Ye J (2004). Proteolytic activation of sterol regulatory element-binding protein induced by cellular stress through depletion of Insig-1. J Biol Chem 279, 45257-45265. (Pubitemid 39430941)
25. Lee JP, Brauweiler A, Rudolph M, Hooper JE, Drabkin HA, Gemmill RM (2010). The TRC8 ubiquitin ligase is sterol regulated and interacts with lipid and protein biosynthetic pathways. Mol Cancer Res 8, 93-106.
26. Leichner GS, Avner R, Harats D, Roitelman J (2009). Dislocation of HMG-CoA reductase and Insig-1, two polytopic endoplasmic reticulum proteins, en route to proteasomal degradation. Mol Biol Cell 20, 3330-3341.
27. Leichner GS, Avner R, Harats D, Roitelman J (2011). Metabolically regulated endoplasmic reticulum-associated degradation of 3-hydroxy-3- methylglutaryl-CoA reductase: evidence for requirement of a geranylgeranylated protein. J Biol Chem 286, 32150-32161.
28. Liscum L, Cummings RD, Anderson RG, DeMartino GN, Goldstein JL, Brown MS (1983a). 3-Hydroxy-3-methylglutaryl-CoA reductase: a transmembrane glycoprotein of the endoplasmic reticulum with N-linked "high-mannose" oligosaccharides. Proc Natl Acad Sci USA 80,7165-7169. (Pubitemid 14207375)
29. Liscum L, Luskey KL, Chin DJ, Ho YK, Goldstein JL, Brown MS (1983b). Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and its mRNA in rat liver as studied with a monoclonal antibody and a cDNA probe. J Biol Chem 258, 8450-8455.
30. Liu TF, Tang JJ, Li PS, Shen Y, Li JG, Miao HH, Li BL, Song BL (2012). Ablation of gp78 in liver improves hyperlipidemia and insulin resistance by inhibiting SREBP to decrease lipid biosynthesis. Cell Metab 16, 213-225.
31. Lloyd-Jones D et al. (2009). Heart disease and stroke statistics-2009 update:a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119, 480-486.
32. Mittelstadt PR, Monteiro JP, Ashwell JD (2012). Thymocyte responsiveness to endogenous glucocorticoids is required for immunological fitness. J Clin Invest 122, 2384-2394.
33. Nadav E, Shmueli A, Barr H, Gonen H, Ciechanover A, Reiss Y (2003). A novel mammalian endoplasmic reticulum ubiquitin ligase homologous to the yeast Hrd1. Biochem Biophys Res Commun 303, 91-97. (Pubitemid 36338212)
34. Nakanishi M, Goldstein JL, Brown MS (1988). Multivalent control of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Mevalonate-derived product inhibits translation of mRNA and accelerates degradation of enzyme. J Biol Chem 263, 8929-8937.
35. Neutzner A, Neutzner M, Benischke AS, Ryu SW, Frank S, Youle RJ, Karbowski M (2011). A systematic search for endoplasmic reticulum (ER) membrane-associated RING finger proteins identifies Nixin/ZNRF4 as a regulator of calnexin stability and ER homeostasis. J Biol Chem 286, 8633-8643.
36. Palombella VJ, Rando OJ, Goldberg AL, Maniatis T (1994). The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell 78, 773-785. (Pubitemid 24294453)
37. Pearce MM, Wang Y, Kelley GG, Wojcikiewicz RJ (2007). SPFH2 mediates the endoplasmic reticulum-associated degradation of inositol 1,4,5-trisphosphate receptors and other substrates in mammalian cells. J Biol Chem 282, 20104-20115. (Pubitemid 47099990)
38. Pearce MM, Wormer DB, Wilkens S, Wojcikiewicz RJ (2009). An endoplasmic reticulum (ER) membrane complex composed of SPFH1 and SPFH2 mediates the ER-associated degradation of inositol 1,4,5-trisphosphate receptors. J Biol Chem 284, 10433-10445.
39. Persengiev SP, Zhu X, Green MR (2004). Nonspecific, concentration- dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs). RNA 10, 12-18. (Pubitemid 38018731)
40. Ravid T, Doolman R, Avner R, Harats D, Roitelman J (2000). The ubiquitin-proteasome pathway mediates the regulated degradation of mammalian 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J Biol Chem 275, 35840-35847.
41. Roitelman J, Masson D, Avner R, Ammon-Zufferey C, Perez A, Guyon-Gellin Y, Bentzen CL, Niesor EJ (2004). Apomine, a novel hypocholesterolemic agent, accelerates degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and stimulates low density lipoprotein receptor activity. J Biol Chem 279, 6465-6473. (Pubitemid 38248780)
42. Roitelman J, Olender EH, Bar-Nun S, Dunn WAJ, Simoni RD (1992). Immunological evidence for eight spans in the membrane domain of 3-hydroxy-3-methylglutaryl coenzyme A reductase: implications for enzyme degradation in the endoplasmic reticulum. J Cell Biol 117, 959-973.
43. Roitelman J, Simoni RD (1992). Distinct sterol and nonsterol signals for the regulated degradation of 3-hydroxy-3-methylglutaryl-CoA reductase. J Biol Chem 267, 25264-25273.
44. Sanford LP, Kallapur S, Ormsby I, Doetschman T (2001). Influence of genetic background on knockout mouse phenotypes. Methods Mol Biol 158, 217-225.
45. Semizarov D, Frost L, Sarthy A, Kroeger P, Halbert DN, Fesik SW (2003). Specificity of short interfering RNA determined through gene expression signatures. Proc Natl Acad Sci USA 100, 6347-6352. (Pubitemid 36666584)
46. Sever N, Song BL, Yabe D, Goldstein JL, Brown MS, DeBose-Boyd RA (2003a). Insig-dependent ubiquitination and degradation of mammalian 3-hydroxy-3-methylglutaryl-CoA reductase stimulated by sterols and geranylgeraniol. J Biol Chem 278, 52479-52490. (Pubitemid 38035841)
47. Sever N, Yang T, Brown MS, Goldstein JL, DeBose-Boyd RA (2003b). Accelerated degradation of HMG CoA reductase mediated by binding of insig-1 to its sterol-sensing domain. Mol Cell 11, 25-33. (Pubitemid 36126588)
48. Shmueli A, Tsai YC, Yang M, Braun MA, Weissman AM (2009). Targeting of gp78 for ubiquitin-mediated proteasomal degradation by Hrd1: cross-talk between E3s in the endoplasmic reticulum. Biochem Biophys Res Commun 390, 758-762.
49. Song BL, Sever N, DeBose-Boyd RA (2005). Gp78, a membrane-anchored ubiquitin ligase, associates with Insig-1 and couples sterol-regulated ubiquitination to degradation of HMG CoA reductase. Mol Cell 19, 829-840. (Pubitemid 41316676)
50. Steinberg D (2006). Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy, part V: the discovery of the statins and the end of the controversy. J Lipid Res 47, 1339-1351.
51. Takaishi K, Duplomb L, Wang MY, Li J, Unger RH (2004). Hepatic insig-1 or -2 overexpression reduces lipogenesis in obese Zucker diabetic fatty rats and in fasted/refed normal rats. Proc Natl Acad Sci USA 101, 7106-7111. (Pubitemid 38596450)
52. Tsai YC et al. (2007). The ubiquitin ligase gp78 promotes sarcoma metastasis by targeting KAI1 for degradation. Nat Med 13, 1504-1509. (Pubitemid 350224250)
53. Tsai YC, Weissman AM (2010). The unfolded protein response, degradation from endoplasmic reticulum and cancer. Genes Cancer 1, 764-778.
54. Vembar SS, Brodsky JL (2008). One step at a time: endoplasmic reticulum-associated degradation. Nat Rev Mol Cell Biol 9, 944-957.
55. Wang Y et al. (2009). SPFH1 and SPFH2 mediate the ubiquitination and degradation of inositol 1,4,5-trisphosphate receptors in muscarinic receptor-expressing HeLa cells. Biochim Biophys Acta 1793, 1710-1718.
56. Yamaguchi T, Sharma P, Athanasiou M, Kumar A, Yamada S, Kuehn MR (2005). Mutation of SENP1/SuPr-2 reveals an essential role for desumoylation in mouse development. Mol Cell Biol 25, 5171-5182. (Pubitemid 40781115)
57. Yang T, Espenshade PJ, Wright ME, Yabe D, Gong Y, Aebersold R, Goldstein JL, Brown MS (2002). Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER. Cell 110, 489-500. (Pubitemid 35232292)